Industry News
Cell-based alternative to animal testing
An alternative to animal testing, laboratory-grown human cells may be used to classify chemicals as sensitising, or non-sensitising, and can even predict the strength of allergic response.
[ + ]National Science Week has been launched
National Science Week 2011 was officially launched at the Queensland Museum by Australia's Chief Scientist Professor Ian Chubb AC.
[ + ]New technology to reduce research time
The Maia X-ray detector can produce high definition images that show detail to 1000th of a millimetre, which may reduce research time by days or even weeks.
[ + ]Blood antibody test not accurate for active TB diagnosis
The World Health Organization has recommended against the use of commercial serology tests in the diagnosis of active TB after reports that they are neither accurate nor cost-effective.
[ + ]Vastly increased explosive force for weaponry
A High-Density Reactive Material has the potential to dramatically increase the explosive impact of most weapons with little or no compromise in strength or design.
[ + ]Genetic study hones in on causes of MS
29 genes influencing multiple sclerosis (MS) have been uncovered in an international GWAS study, showing the immune system and T cells play a crucial role in the disease. [ + ]
Many genes make you smart
New insight into the genetic basis of intelligence shows that many small variations contribute to someone's intelligence. [ + ]
Free seminar on optical scanning
Rheology Solutions and Optical Control Systems (OCS) are running a free joint workshop on optical scanning on Tuesday 6 September 2011.
[ + ]Cochlear posts 16% jump in profit for FY11
Proving that market jitters don’t necessarily reflect underlying profitability, Cochlear has posted a 10% increase in revenue and 16% jump in profit for FY11. [ + ]
Market watch: Biotechs take battering as markets lurch
Biotechnology stocks haven’t been spared the tumult of the market with several falls of over 5% today. [ + ]
New molecules offer hope for treating HIV and cancer
The discovery of two molecules that block endocytosis opens up the possibility of selectively preventing viruses like HIV from infecting cells and for halting the growth of cancers. [ + ]
Bionomics to extend trials of ovarian cancer treatment
Trials of BNC105 in combination with existing chemotherapy drugs to treat ovarian cancer. [ + ]
Funding to commercialise new needle-free vaccine delivery technology
OneVentures and Vaxxas Pty Ltd investment will enable Professor Mark Kendall of UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) to continue his pioneering research and development of the Nanopatch.
[ + ]Nobel Prize winner to strengthen national science body
Nobel Prize winner Professor Peter Doherty will join the National Science Colloquium of the Australian Synchrotron.
[ + ]Vaxxas gets $15m injection to develop needle-free vaccine
Biotech start-up Vaxxas has received a $15m venture capital kick start to commercialise needle-free vaccine delivery system Nanopatch. [ + ]
